Panel - Envisioning the Future Landscape of Quantitative Pharmacology and MIDD for Next-Generation RNA Therapeutics

Panelist(s)

• 

  Zheng Yang, PhD

  Principal
  Excelsius LLC., Massachusetts, United States
• 

  Rodrigo Cristofoletti, PhD

  Associate Professor
  University of Florida, Florida, United States
• KM

  Kenji Miyazawa, PhD (he/him/his)

  Senior Scientist, Quantitative Systems Pharmacology
  Moderna, Inc.
  Malden, Massachusetts, United States
• 

  Jiawei Zhou, PhD (she/her/hers)

  Assistant Professor
  UNC-Chapel Hill, North Carolina, United States